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Introduction: 
Sore throat is a common, usually self-limiting upper respiratory tract infection. Public Health England have 
reported that 20% of all antibiotic prescriptions are inappropriate1, with antibiotics prescribed in 59% of 
acute sore throat consultations compared to an ‘ideal’ of 13%2. Several factors, including antibiotic misuse, 
have led to increasing antibiotic resistance3 which is a threat to public health and rising costs of healthcare 
services. Independent pharmacist prescribers employed by GP practices are becoming more commonplace 
and there is little research evaluating their prescribing trends in the management of acute sore throat.  
 
Aim:  




The management of sore throats at the Medical Practice followed NICE CG84. Five audit standards were 
created in line with this guidance: (1) 100% of patients assigned a feverPAIN score; (2) 100% of patients 
provided with appropriate self-care advice; (3) 80% of antibiotic prescribing is based on patients’ feverPAIN 
score; (4) 100% of antibiotic prescription regimens are correct; (5) 80% of patients do not require a re-
consultation for sore throat symptoms. Data of patients who presented to the pharmacist with sore throat 
symptoms between 29/03/2018 and 03/10/2018 were extracted from EMIS and transferred into an 
anonymised spreadsheet. Data was analysed descriptively against the audit standards. 
 
Results:  
Prescribing data from 124 patients was extracted from EMIS. Adherence to the prescribing guidelines was 
high, with use of the feverPAIN scoring system in 100% of consultations and appropriate advice given on all 
occasions. Antibiotics were prescribed appropriately in-line with patient’s feverPAIN scores in 92% of 
consultations. Antibiotic choice, dose and frequency were appropriate for 97% of patients (1 patient 
prescribed phenoxymethylpenicillin was found to be allergic to it) and duration of treatment for 78% of 
patients (course length of Macrolides reduced in 2018 from seven to five days). Re-consultation rates were 
low at only 14%, with the majority of these patients having not received an antibiotic at initial presentation. 
Of all patients presenting with sore throat, 30% received antibiotics in the study time period. 
Conclusion:  
High adherence to the clinical guideline suggests the management of sore throat is within a pharmacist 
prescriber’s competence and their professional judgement can aid patient-centred care. Antibiotic 
prescribing in this audit was lower than the national average of 59%, but higher than the recommended 13%, 
thus measures can be implemented to ensure adherence is high whilst over-prescribing is minimised.  
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